Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 3,083,501 8.600% | -304,875 (-9.00%) | Filing History |
| 2022-02-14 11:55 am Sale | 2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Eventide Asset Management, LLC | 42,499 0.100% | -2,795,626 (-98.50%) | Filing History |
| 2022-02-11 1:51 pm Purchase | 2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | CHI Advisors LLC | 2,569,479 7.130% | 214,680 (+9.12%) | Filing History |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Pliant Therapeutics, Inc. PLRX | FMR LLC | 5,405,849 14.999% | 83,693 (+1.57%) | Filing History |
| 2021-03-02 3:41 pm Purchase | 2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | CHI Advisors LLC | 2,354,799 6.600% | 2,354,799 (New Position) | Filing History |
| 2021-02-16 4:17 pm Purchase | 2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Third Rock Ventures III L.P. | 5,839,160 16.500% | 5,839,160 (New Position) | Filing History |
| 2021-02-16 4:08 pm Sale | 2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 3,388,376 9.600% | -22,281 (-0.65%) | Filing History |
| 2021-02-12 4:11 pm Purchase | 2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Eventide Asset Management, LLC | 2,838,125 8.000% | 2,838,125 (New Position) | Filing History |